Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Cacopardo

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Biomedicines|October 26, 2024
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC CohortAgnese Colpani, Andrea De Vito, Andrea Marino, et al.
The American Journal of Gastroenterology|May 29, 2019
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL ExperienceVincenza Calvaruso, Irene Cacciola, Anna Licata, et al.
Plos One|February 21, 2018
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patientsLucia Taramasso, Antonio Di Biagio, Francesca Bovis, et al.
Jac-Antimicrobial Resistance|July 8, 2025
Impact of multidrug resistance in cancer patients with bloodstream infections caused by Gram-negative bacilli: results from a multicentre studyMarco Falcone, Sergio Carbonara, Andrea Marino, et al.
Viruses|November 27, 2025
Efficacy and Safety of Cabotegravir-Rilpivirine in PLWH: A Real-World StudyGiuseppe Nicolò Conti, Serena Spampinato, Andrea De Vito, et al.
Pathogens (Basel, Switzerland)|July 30, 2025
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks EvaluationSerena Spampinato, Emmanuele Venanzi Rullo, Giuseppe Nicolò Conti, et al.
Infection|December 6, 2024
Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in ItalyGiusy Tiseo, Valentina Galfo, Sergio Carbonara, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 21, 2023
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)Marco Falcone, Giusy Tiseo, Sergio Carbonara, et al.
Infectious Diseases and Therapy|July 12, 2024
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort StudyDaniele Roberto Giacobbe, Laura Labate, Chiara Russo Artimagnella, et al.
Jac-Antimicrobial Resistance|October 8, 2025
Use of isavuconazole in critically ill patients in intensive care units: a prospective, observational, multicentre, cohort studyDaniele Roberto Giacobbe, Claudia Bartalucci, Martina Bavastro, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Biomedicines|October 26, 2024
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC CohortAgnese Colpani, Andrea De Vito, Andrea Marino, et al.
The American Journal of Gastroenterology|May 29, 2019
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL ExperienceVincenza Calvaruso, Irene Cacciola, Anna Licata, et al.
Plos One|February 21, 2018
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patientsLucia Taramasso, Antonio Di Biagio, Francesca Bovis, et al.
Jac-Antimicrobial Resistance|July 8, 2025
Impact of multidrug resistance in cancer patients with bloodstream infections caused by Gram-negative bacilli: results from a multicentre studyMarco Falcone, Sergio Carbonara, Andrea Marino, et al.
Viruses|November 27, 2025
Efficacy and Safety of Cabotegravir-Rilpivirine in PLWH: A Real-World StudyGiuseppe Nicolò Conti, Serena Spampinato, Andrea De Vito, et al.
Pathogens (Basel, Switzerland)|July 30, 2025
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks EvaluationSerena Spampinato, Emmanuele Venanzi Rullo, Giuseppe Nicolò Conti, et al.
Infection|December 6, 2024
Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in ItalyGiusy Tiseo, Valentina Galfo, Sergio Carbonara, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 21, 2023
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)Marco Falcone, Giusy Tiseo, Sergio Carbonara, et al.
Infectious Diseases and Therapy|July 12, 2024
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort StudyDaniele Roberto Giacobbe, Laura Labate, Chiara Russo Artimagnella, et al.
Jac-Antimicrobial Resistance|October 8, 2025
Use of isavuconazole in critically ill patients in intensive care units: a prospective, observational, multicentre, cohort studyDaniele Roberto Giacobbe, Claudia Bartalucci, Martina Bavastro, et al.
Pageof 12